<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-11-05 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-11-05/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-11-05"><meta property="og:description" content="ğŸ“… Daily Report - 2025-11-05 ä»Šæ—¥ç­›é€‰å‡º 92 æ¡å†…å®¹ï¼Œæ¥è‡ª 5 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-11-05T00:00:00+00:00"><meta property="article:modified_time" content="2025-11-05T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week452025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-11-05"><meta itemprop=description content="ğŸ“… Daily Report - 2025-11-05 ä»Šæ—¥ç­›é€‰å‡º 92 æ¡å†…å®¹ï¼Œæ¥è‡ª 5 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-11-05T00:00:00+00:00"><meta itemprop=dateModified content="2025-11-05T00:00:00+00:00"><meta itemprop=wordCount content="3355"><meta itemprop=keywords content="Research,Daily,Week452025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-11-05"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-11-05 ä»Šæ—¥ç­›é€‰å‡º 92 æ¡å†…å®¹ï¼Œæ¥è‡ª 5 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-05</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-11-05T00:00:00Z>2025-11-05</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</a></li><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </a></li><li><a href=#-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-11-05>ğŸ“… Daily Report - 2025-11-05</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>92</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>5</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ–°å‹å·¥å…·é›†ï¼ˆç©ºé—´å¤šç»„å­¦æ•´åˆã€å•ç»†èƒæ‰¹æ¬¡æ•´åˆã€å¯å˜å‰ªåˆ‡ã€å‘è‚²æ½œèƒ½é¢„æµ‹ï¼‰å…¨é¢å‡çº§ï¼Œä¸ºå¥åº·æˆå¹´äººå…ç–«è€åŒ–ç ”ç©¶æä¾›å¼ºå¤§æ”¯æŒã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>ç»†èƒè¡°è€ä¸ç–¾ç—…ç ”ç©¶</strong>ï¼šèšç„¦éè‚¿ç˜¤ç–¾ç—…ï¼Œåˆ©ç”¨æœºå™¨å­¦ä¹ ã€å•ç»†èƒæµ‹åºã€PANoptosisç­‰çƒ­ç‚¹ï¼Œæ·±å…¥æ¢ç©¶ç»†èƒè¡°è€åœ¨ç–¾ç—…ä¸­çš„ç‰¹å¾ä¸æœºåˆ¶ã€‚</li><li><strong>è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒç ”ç©¶</strong>ï¼šé€šè¿‡ç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯ï¼ˆå¦‚visiumï¼‰å’Œæœºå™¨å­¦ä¹ ï¼Œæ·±å…¥è§£æè‚¿ç˜¤ç»†èƒè¡°è€è¡¨å‹ã€CAFçš„è¡°è€ç‰¹å¾åŠè‚¿ç˜¤å…ç–«æµ¸æ¶¦ã€‚</li><li><strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šç»“åˆè›‹ç™½è´¨ç»„ã€è½¬å½•ç»„ã€å…¨è½¬å½•ç»„å…³è”ç ”ç©¶ï¼ˆTWASï¼‰åŠå•ç»†èƒæ•°æ®ï¼Œæ„å»ºç–¾ç—…åˆ†å‹ä¸æ¨¡å‹ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>ç©ºé—´å¤šç»„å­¦æ™ºèƒ½æ•´åˆä¸è°ƒæ§ç½‘ç»œæ¨æ–­</strong>ï¼šçªç ´æ€§åœ°å®ç°ç©ºé—´å¤šç»„å­¦æ•°æ®æ•´åˆä¸ç½‘ç»œæ¨æ–­ã€‚</li><li><strong>æ–°å‹åŸºå› é€‰æ‹©å·¥å…·GeneSelectR</strong>ï¼šå®ç°ä¸€é”®å¤šæ–¹æ³•ç‰¹å¾é€‰æ‹©ä¸å¯Œé›†åˆ†æã€‚</li><li><strong>metaforåŒ…é€‰æ‹©æ¨¡å‹</strong>ï¼šç”¨äºæ ¡æ­£å‘è¡¨åå€šï¼Œæä¾›æ›´å‡†ç¡®çš„Metaåˆ†æä¼°è®¡å€¼ã€‚</li></ul><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
Eukaryotic Translation Initiation Factor 3m (eIF3m) åœ¨å¿ƒè‚Œç¼ºè¡€å†çŒæ³¨æŸä¼¤ä¸­è°ƒæ§ç¡åŒ–æŸä¼¤ï¼Œæ­ç¤ºå…¶ä½œä¸ºå¿ƒåŠ›è¡°ç«­é¢„åæŒ‡æ ‡çš„ç‹¬ç‰¹ä½œç”¨ï¼›THOC5 ä¾èµ–çš„è½¬å½•åè°ƒæ§ç»´æŒè¡€ç®¡å¹³æ»‘è‚Œç»†èƒç¨³æ€ï¼Œå¯¹æŠ—æ…¢æ€§è‚¾ç—…ç›¸å…³è¡€ç®¡é’™åŒ–ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ¢ç©¶ RNA ç»“åˆè›‹ç™½åœ¨å¿ƒåŠ›è¡°ç«­ã€è¡€ç®¡é’™åŒ–ã€æ€¥æ€§å‘¼å¸çª˜è¿«ç»¼åˆå¾ç­‰ç–¾ç—…å‘ç”Ÿå‘å±•ä¸­çš„è°ƒæ§æœºåˆ¶ã€‚</li><li>åŸºäºå•ç»†èƒ RNA-seq å’Œå¤šç»„å­¦åˆ†æï¼Œè§£æå…ç–«ç»†èƒã€é€ è¡€å¹²ç»†èƒã€è¡€ç®¡å¹³æ»‘è‚Œç»†èƒç­‰åœ¨ç–¾ç—…æ¨¡å‹ä¸­çš„åŠŸèƒ½å’Œåˆ†åŒ–é€šè·¯ã€‚</li><li>ç ”ç©¶è½¬å½•å› å­ã€è¡¨è§‚é—ä¼ ä¿®é¥°ï¼ˆå¦‚ä¹™é…°åŒ– HDAC1ï¼‰åœ¨è¡€ç®¡ç”Ÿæˆã€ç»†èƒåˆ†åŒ–ä¸­çš„ä½œç”¨ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ç»“åˆ ClIP-Seqã€Ribo-Seqã€RNA-Seqã€Mt2RNAseqã€RIP-seqã€ChIP-seqã€scRNA-seq ç­‰å¤šç§é«˜é€šé‡æµ‹åºæŠ€æœ¯ï¼Œå®ç°å¯¹ RNA ç»“åˆæ¨¡å¼ã€è½¬å½•ç»„ã€åŸºå› ç»„ç»“åˆä½ç‚¹ã€ç»†èƒå¼‚è´¨æ€§çš„å…¨é¢è§£æã€‚</li><li>å‘å±•å’Œä¼˜åŒ–ç”¨äºäººç±»å•æ ¸ç»†èƒæ¥æºå·¨å™¬ç»†èƒçš„å¤šç»„å­¦åˆ†ææ–¹æ¡ˆã€‚</li></ul><h3 id=-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
ç™Œç—‡ç ”ç©¶æ­£ç»å†å˜é©æ—¶ä»£ï¼Œå…ç–«ç–—æ³•ã€æ—©æœŸæ£€æµ‹ã€ç²¾å‡†è‚¿ç˜¤å­¦å’Œäººå·¥æ™ºèƒ½é©±åŠ¨çš„çªç ´æœ‰æœ›é‡å¡‘æ²»ç–—å’Œç”Ÿå­˜ç‡ï¼Œä½†éœ€å…¨çƒåä½œæŠ•èµ„å’Œå…¬å¹³æ€§ä¿éšœã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>å…ç–«æ²»ç–—ç–—æ•ˆè°ƒæ§</strong>ï¼šæ­ç¤ºéè¥å…»æ€§ç”œå‘³å‰‚é€šè¿‡å¾®ç”Ÿç‰©ç¾¤å’Œä»£è°¢ç‰©è°ƒèŠ‚ï¼ŒæŸå®³æŠ— PD-1 æ²»ç–—ç–—æ•ˆï¼Œæç¤ºç”Ÿæ´»æ–¹å¼å¹²é¢„çš„ä¸´åºŠç›¸å…³æ€§ã€‚</li><li><strong>å‰åˆ—è…ºç™Œæ²»ç–—æ–°ç­–ç•¥</strong>ï¼šå‘ç°é›„æ¿€ç´ å—ä½“ï¼ˆARï¼‰è›‹ç™½åˆæˆçš„ä»£è°¢è„†å¼±æ€§ï¼Œéš”æ—¥ç¦é£Ÿï¼ˆADFï¼‰é€šè¿‡è¯±å¯¼ AR mRNA æ ¸ç³–ä½“ç¢°æ’æ¥æŸå®³ AR ç¿»è¯‘ï¼Œä¸ºè€è¯æ€§æ²»ç–—æä¾›æ–°æ€è·¯ã€‚</li><li><strong>è‚¥èƒ–ä¸ç™Œç—‡å…³è”ç ”ç©¶</strong>ï¼šGLP-1 å—ä½“æ¿€åŠ¨å‰‚å±•ç°å‡ºé€†è½¬è‚¥èƒ–ç›¸å…³ç™Œç—‡é£é™©çš„æ½œåŠ›ï¼Œä½†éœ€æ·±å…¥ç†è§£å…¶æœºåˆ¶å’Œå…¨é¢åº”ç”¨ã€‚</li><li><strong>è‚¿ç˜¤ä¼‘çœ æœºåˆ¶æ¢ç´¢</strong>ï¼šè¯†åˆ«å‡ºè‚ºå†…çš®è›‹ç™½ PEAR1 åœ¨è¯±å¯¼è‚¿ç˜¤ç»†èƒä¼‘çœ ä¸­çš„å…³é”®ä½œç”¨ï¼Œä¸ºç†è§£å’Œå¹²é¢„è¿œå¤„è½¬ç§»æä¾›æ–°è§†è§’ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>æŠ—ä½“-è¯ç‰©å¶è”ç‰©ï¼ˆADCï¼‰</strong>ï¼šè¯¥é¢†åŸŸå‘å±•è¿…é€Ÿï¼Œå…¶åˆ†å­è®¾è®¡ã€ç»“æ„æˆåˆ†ï¼ˆæŠ—ä½“ã€æ¥å¤´ã€è½½è·ï¼‰åŠä½œç”¨æœºåˆ¶ï¼ˆå¦‚è¯±å¯¼å…ç–«åŸæ€§ç»†èƒæ­»äº¡ ICDï¼‰æ˜¯æ¨åŠ¨ä¸´åºŠè½¬åŒ–çš„å…³é”®ã€‚</li></ul><h3 id=-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
R Shiny å¼•å…¥ Behavior-Driven Development (BDD) çš„æµ‹è¯•å‰ç½®æ¡ä»¶è®¾ç½®æ–¹æ³•ï¼Œä»¥åŠ maestro 0.7.0 ç‰ˆæœ¬å®ç°æ¡ä»¶åŒ–æ‰§è¡Œç®¡é“ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æå‡ R Shiny åº”ç”¨çš„æµ‹è¯•å¯é æ€§ã€‚</li><li>å®ç°å¤æ‚æ•°æ®å¤„ç†æµç¨‹çš„çµæ´»æ‰§è¡Œã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>R Shiny BDD é€šè¿‡ &ldquo;Given&rdquo; æ­¥éª¤å®ç°ä¾èµ–æ³¨å…¥ã€æµ‹è¯•æ›¿èº«å’Œå¯ç»„åˆè®¾ç½®æ¨¡å¼ã€‚</li><li>maestro 0.7.0 å¼•å…¥æ¡ä»¶åŒ–æ‰§è¡Œç®¡é“ï¼Œæ”¯æŒåœ¨æœ‰å‘æ— ç¯å›¾ (DAG) ç»“æ„ä¸­å®ç°åˆ†æ”¯æˆ–é€‰æ‹©æ€§æ‰§è¡Œã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
å•ç»†èƒRNAæµ‹åºæ­ç¤ºäº†å·¨å™¬ç»†èƒä¸­çš„å¹²æ‰°ç´ ä¿¡å·é€šè·¯å¦‚ä½•é©±åŠ¨è‚¾ç™Œå…ç–«æ²»ç–—è€è¯æ€§ï¼Œä¸ºç”Ÿç‰©æ ‡å¿—ç‰©å‘ç°å’Œæ²»ç–—ç­–ç•¥æä¾›äº†æ–°è§è§£ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ¢ç´¢è‚¾ç™Œå…ç–«æ²»ç–—è€è¯æœºåˆ¶</li><li>ç ”ç©¶é•¿è¯»é•¿RNAæµ‹åºåœ¨åŒºåˆ†ciså’Œtransè°ƒæ§çš„RNAå‰ªæ¥ä¸­çš„åº”ç”¨</li><li>åˆ©ç”¨ä¸‹ä¸€ä»£åŸºå› æµ‹åºæŠ€æœ¯æå‡å…½åŒ»è¯Šæ–­èƒ½åŠ›å’ŒåŠ¨ç‰©å¥åº·ç›‘æµ‹</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å•ç»†èƒRNAæµ‹åºæŠ€æœ¯åœ¨æ­ç¤ºç»†èƒå¼‚è´¨æ€§é©±åŠ¨çš„å…ç–«æ²»ç–—è€è¯æ€§ä¸­çš„åº”ç”¨ã€‚</li><li>é•¿è¯»é•¿RNAæµ‹åºæŠ€æœ¯ç”¨äºç²¾ç¡®åŒºåˆ†ciså’Œtranså‰ªæ¥è°ƒæ§å…ƒä»¶ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“° å…¬ä¼—å· (26æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>å¥åº·æˆå¹´äººå…ç–«è€åŒ–å…¨æ™¯å›¾ï¼›ç©ºé—´å¤šç»„å­¦æ™ºèƒ½æ•´åˆä¸è°ƒæ§ç½‘ç»œæ¨æ–­ã€å•ç»†èƒæ‰¹æ¬¡æ•´åˆã€å•ç»†èƒå¯å˜å‰ªåˆ‡ã€å‘è‚²æ½œèƒ½é¢„æµ‹ç­‰å·¥å…·ä¸Šæ–° |å•ç»†èƒè§†è§’</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€å•ç»†èƒã€ç©ºé—´ç»„å­¦</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533477&amp;idx=1&amp;sn=daf8c8ee0fd42dcd889437aac72a9a76">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>9.4åˆ†éè‚¿ç˜¤ç”Ÿä¿¡ï¼Œè¡°è€+æœºå™¨å­¦ä¹ +åˆ†å‹+å…ç–«æµ¸æ¶¦+è¡¨è¾¾éªŒè¯ã€‚è¿™æˆ‘ä¹Ÿèƒ½åšå‘€ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å…ç–«ã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503824&amp;idx=4&amp;sn=8f76b0533d1a608e8bb2ea6c4d894ade">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>éè‚¿ç˜¤çº¯ç”Ÿä¿¡ï¼ŒåŸºäºæœºå™¨å­¦ä¹ ï¼Œæ— ç›‘ç£èšç±»ç­‰ç ”ç©¶ç»†èƒè¡°è€åœ¨ç–¾ç—…ä¸­çš„ç‰¹å¾ã€‚è¡°è€çƒ­ç‚¹ç»ä¹…ä¸è¡°ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡ã€èšç±»</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503824&amp;idx=2&amp;sn=c47f1a491567d4f934a11206dce7e27a">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>æœ€æ–°8.1åˆ†éè‚¿ç˜¤ç”Ÿä¿¡ï¼Œé’ˆå¯¹PANoptosisçƒ­ç‚¹è¿›è¡Œæœºå™¨å­¦ä¹ +å•ç»†èƒç­›é€‰+ç®€å•éªŒè¯ï¼Œå…¨æ–‡åªæœ‰4ä¸ªFigureï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€å•ç»†èƒã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503824&amp;idx=1&amp;sn=57ca959a005a04d9cd4410f16d895348">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>å¤æ—¦å¤§å­¦å‘ Nat Cancer |ä¸´åºŠè¯•éªŒ+å•ç»†èƒæµ‹åºï¼Œçœ‹çœ‹ä»–ä»¬æ˜¯æ€ä¹ˆåšçš„</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡é’±åŒå­¦</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€æµ‹åºã€å•ç»†èƒ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šä¸´åºŠå®éªŒé…åˆå•ç»†èƒæµ‹åº</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495403&amp;idx=1&amp;sn=464b38cbd7349648d4d8113aec4d6f0c">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>æ–‡çŒ®åˆ†äº«|Nature Communications: å››å¤§ç©ºé—´è½¬å½•ç»„å¹³å°æ€§èƒ½å¤§æ¯”æ‹¼ï¼šè°åœ¨è‚¿ç˜¤ç ”ç©¶ä¸­æ›´èƒœä¸€ç­¹ï¼Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç‹æ°¸æˆLab</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç©ºé—´è½¬å½•ç»„ã€è½¬å½•ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šNature Communicationsè¿‘å¹´æ¥ï¼Œç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯åœ¨åˆ†è¾¨ç‡ä¸é€šé‡æ–¹é¢å–å¾—æ˜¾è‘—çªç ´ï¼Œä½†ç°æœ‰æŠ€æœ¯è¯„</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzkxMDY1MjU1OA==&amp;mid=2247488446&amp;idx=1&amp;sn=559764a9995cc412c84f5ebae068b2c7">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>æœ€æ–°5.7åˆ†ç”Ÿä¿¡ï¼Œå•ç»†èƒæ³›ç™Œ+ç©ºè½¬æ³›ç™Œ+ç™¾ç§æœºå™¨å­¦ä¹ ç ”ç©¶CAFçš„è¡°è€è¡¨å‹ï¼ŒæŠ•ç¨¿åˆ°æ¥æ”¶ä»…48å¤©ï¼Œå¯è°“æ˜¯æ°´åˆŠä¸­çš„å¤©èŠ±æ¿ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503824&amp;idx=7&amp;sn=a41c1eee969ebc64c35bd1079c262907">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>5æœˆæœ€æ–°10+ç”Ÿä¿¡ï¼ŒåŸºäºç»†èƒæ­»äº¡å’Œè¡°è€çš„è‚¿ç˜¤åˆ†å‹åŠæ¨¡å‹æ„å»ºï¼Œåˆ†æä¸éš¾ï¼Œå®éªŒåªæœ‰åŠä¸ªfigureï¼Œå€¼å¾—å­¦ä¹ ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503824&amp;idx=6&amp;sn=34a846bbfdc98165c172a8b3b8d8f4ef">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>15.7åˆ†çº¯ç”Ÿä¿¡ï¼ŒåŸºäºå•ç»†èƒæ„å»ºç»†èƒè¡°è€çš„ç»†èƒç±»å‹ç‰¹å¼‚æ€§å›¾è°±ã€‚è‡ªå®šä¹‰ç®—æ³•é‰´å®šå‡ºæ–°çš„è¡°è€åŸºå› é›†ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503824&amp;idx=3&amp;sn=1eacdde390df0a070b63975b9c529cbe">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>è›‹ç™½è´¨ç»„è½¬å½•ç»„åˆ†æä¸¤ä¸‰äº‹ï¼šKEGGå·²ç»ä¸æ˜¯ä»¥å‰çš„KEGGäº†</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šDr.Xçš„åŸºå› ç©ºé—´</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè½¬å½•ç»„ã€è›‹ç™½è´¨ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šæ—§ä»£ç éœ€è¦å®šæœŸæ£€æŸ¥è¿è¡Œç¨³å®šæ€§ï¼Œç‰¹åˆ«æ˜¯ä»£ç ä¸­ä¾èµ–åˆ°ç¬¬ä¸‰æ–¹æ•°æ®åº“å’Œç½‘ç«™æ—¶ï¼Œéœ€è¦è­¦æƒ•å¤–éƒ¨å˜åŒ–ä¸ºå†…éƒ¨åˆ†æå¸¦æ¥ä¸å¯å¿½è§†çš„å½±å“</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU3MTc2NDI4Mw==&amp;mid=2247486659&amp;idx=1&amp;sn=b3d0fd6f227a91f5306e359763dbb5ed">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 16 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E5%85%AC%E4%BC%97%E5%8F%B7>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (54æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE217286 ç¼ºè¡€æ€§å¿ƒåŠ›è¡°ç«­é¢„åæŒ‡æ ‡çœŸæ ¸ç¿»è¯‘èµ·å§‹å› å­ 3m çš„ RNA ç»“åˆæ¨¡å¼æ­ç¤ºå…¶åœ¨å¿ƒè‚Œç¼ºè¡€å†çŒæ³¨åç¡åŒ–æŸä¼¤è°ƒæ§ä¸­çš„ç‹¬ç‰¹ä½œç”¨ [ClIP-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€leukemiaã€immuneã€immunityã€immunologyã€TMEã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€bioinformaticsã€R packageã€Bioconductorã€Seuratã€epigeneticã€epigenomeã€histoneã€enrichmentã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zilun Wei ; Yongchao Zhao ; Aijun Sun ; Junbo GeSeries Type : OtherOrganism : Homo sapiens ; Rattus norvegicusRNA undergoes various modifications in a manner similar to DNA, thereby opening up the research field of epitranscriptomics. Regulators of mRNA modifications play a role in many molecular processes, biological functions, and disease prognosis. Differential expression profile of RNA modification regulators from HFrEF patientsâ€™ hearts remains deficient at present, let alone their affections on the prognosis. A risk score model based on two modifications-related modulators (eIF3m and Nudt12) was built and screened out with a LASSO regression analysis. Translation dysregulation upon eIF3m knock down in cardiomyocytes was examined by combined high-throughput methods of transcriptome sequencing, ribosome profiling, proteome research, and Clip analyses. Metabolic assays and flux analysis were used to characterize the effects of eIF3m and its downstream mediator in metabolic reprogramming with high-level exogenous TNF-Î± to mimic a highly oxidative inflammatory injury. eIF3m deficiency leads to decoupling of the major steps in translation initiation and elongation. It stabilizes eIF3m-f-h subcomplex through proteasome dependent-polyubiquitination, and controls translational response of specific mRNAs. eIF3m directly binds to Mt2 5â€™ leader to upregulate its translation in NRCMs and H9c2 cells. eIF3m knockdown induced expression of genes involved in proinflammatory and oxidative stress, resulting in 3-NT modification to a key glycolysis enzyme Pfkfb3 when co-cultured with exogenous TNF-Î±. CM-specific eIF3m deletion deteriorates cardiac function and increases infarction size after I/R operation, whereas CM-specific eIF3m overexpression reverses the phenotype. Additionally, eIF3m overexpression inhibits whereas RNAi-mediated Mt2 knockdown activates NF-ÎºB signaling and aggravates nitrative damage. Metabolic analyses highlighted the role for eIF3m in promoting glycolysis and biosynthesis required for functional recovery of the myocardium. Our study demonstrates that the prognosis indicator eIF3m alleviates oxidative inflammatory injury and promotes glycolytic reprograming mainly by binding to Mt2 mRNA. Therapeutic strategies enhancing eIF3m level may possess therapeutic potential against I/R injury.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217286">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE217295 ç¼ºè¡€æ€§å¿ƒåŠ›è¡°ç«­é¢„åæŒ‡æ ‡çœŸæ ¸ç¿»è¯‘èµ·å§‹å› å­ 3m çš„ RNA ç»“åˆæ¨¡å¼æ­ç¤ºå…¶åœ¨å¿ƒè‚Œç¼ºè¡€å†çŒæ³¨åç¡åŒ–æŸä¼¤è°ƒèŠ‚ä¸­çš„ç‹¬ç‰¹ä½œç”¨ [Ribo-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€leukemiaã€immuneã€immunityã€immunologyã€TMEã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€bioinformaticsã€R packageã€Bioconductorã€Seuratã€epigeneticã€epigenomeã€histoneã€enrichmentã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zilun Wei ; Yongchao Zhao ; Aijun Sun ; Junbo GeSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Rattus norvegicusRNA undergoes various modifications in a manner similar to DNA, thereby opening up the research field of epitranscriptomics. Regulators of mRNA modifications play a role in many molecular processes, biological functions, and disease prognosis. Differential expression profile of RNA modification regulators from HFrEF patientsâ€™ hearts remains deficient at present, let alone their affections on the prognosis. A risk score model based on two modifications-related modulators (eIF3m and Nudt12) was built and screened out with a LASSO regression analysis. Translation dysregulation upon eIF3m knock down in cardiomyocytes was examined by combined high-throughput methods of transcriptome sequencing, ribosome profiling, proteome research, and Clip analyses. Metabolic assays and flux analysis were used to characterize the effects of eIF3m and its downstream mediator in metabolic reprogramming with high-level exogenous TNF-Î± to mimic a highly oxidative inflammatory injury. eIF3m deficiency leads to decoupling of the major steps in translation initiation and elongation. It stabilizes eIF3m-f-h subcomplex through proteasome dependent-polyubiquitination, and controls translational response of specific mRNAs. eIF3m directly binds to Mt2 5â€™ leader to upregulate its translation in NRCMs and H9c2 cells. eIF3m knockdown induced expression of genes involved in proinflammatory and oxidative stress, resulting in 3-NT modification to a key glycolysis enzyme Pfkfb3 when co-cultured with exogenous TNF-Î±. CM-specific eIF3m deletion deteriorates cardiac function and increases infarction size after I/R operation, whereas CM-specific eIF3m overexpression reverses the phenotype. Additionally, eIF3m overexpression inhibits whereas RNAi-mediated Mt2 knockdown activates NF-ÎºB signaling and aggravates nitrative damage. Metabolic analyses highlighted the role for eIF3m in promoting glycolysis and biosynthesis required for functional recovery of the myocardium. Our study demonstrates that the prognosis indicator eIF3m alleviates oxidative inflammatory injury and promotes glycolytic reprograming mainly by binding to Mt2 mRNA. Therapeutic strategies enhancing eIF3m level may possess therapeutic potential against I/R injury.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217295">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE217293 ç¼ºè¡€æ€§å¿ƒåŠ›è¡°ç«­é¢„åæŒ‡æ ‡çœŸæ ¸ç¿»è¯‘èµ·å§‹å› å­ 3m çš„ RNA ç»“åˆæ¨¡å¼æ­ç¤ºå…¶åœ¨å¿ƒè‚Œç¼ºè¡€å†çŒæ³¨åç¡åŒ–æŸä¼¤è°ƒæ§ä¸­çš„ç‹¬ç‰¹ä½œç”¨ [RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€leukemiaã€immuneã€immunityã€immunologyã€TMEã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€bioinformaticsã€R packageã€Bioconductorã€Seuratã€epigeneticã€epigenomeã€histoneã€enrichmentã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zilun Wei ; Yongchao Zhao ; Aijun Sun ; Junbo GeSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusRNA undergoes various modifications in a manner similar to DNA, thereby opening up the research field of epitranscriptomics. Regulators of mRNA modifications play a role in many molecular processes, biological functions, and disease prognosis. Differential expression profile of RNA modification regulators from HFrEF patientsâ€™ hearts remains deficient at present, let alone their affections on the prognosis. A risk score model based on two modifications-related modulators (eIF3m and Nudt12) was built and screened out with a LASSO regression analysis. Translation dysregulation upon eIF3m knock down in cardiomyocytes was examined by combined high-throughput methods of transcriptome sequencing, ribosome profiling, proteome research, and Clip analyses. Metabolic assays and flux analysis were used to characterize the effects of eIF3m and its downstream mediator in metabolic reprogramming with high-level exogenous TNF-Î± to mimic a highly oxidative inflammatory injury. eIF3m deficiency leads to decoupling of the major steps in translation initiation and elongation. It stabilizes eIF3m-f-h subcomplex through proteasome dependent-polyubiquitination, and controls translational response of specific mRNAs. eIF3m directly binds to Mt2 5â€™ leader to upregulate its translation in NRCMs and H9c2 cells. eIF3m knockdown induced expression of genes involved in proinflammatory and oxidative stress, resulting in 3-NT modification to a key glycolysis enzyme Pfkfb3 when co-cultured with exogenous TNF-Î±. CM-specific eIF3m deletion deteriorates cardiac function and increases infarction size after I/R operation, whereas CM-specific eIF3m overexpression reverses the phenotype. Additionally, eIF3m overexpression inhibits whereas RNAi-mediated Mt2 knockdown activates NF-ÎºB signaling and aggravates nitrative damage. Metabolic analyses highlighted the role for eIF3m in promoting glycolysis and biosynthesis required for functional recovery of the myocardium. Our study demonstrates that the prognosis indicator eIF3m alleviates oxidative inflammatory injury and promotes glycolytic reprograming mainly by binding to Mt2 mRNA. Therapeutic strategies enhancing eIF3m level may possess therapeutic potential against I/R injury.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217293">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE217285 ç¼ºè¡€æ€§å¿ƒåŠ›è¡°ç«­é¢„åæŒ‡æ ‡çœŸæ ¸ç¿»è¯‘èµ·å§‹å› å­ 3m çš„ RNA ç»“åˆæ¨¡å¼æ­ç¤ºå…¶åœ¨å¿ƒè‚Œç¼ºè¡€å†çŒæ³¨åç¡åŒ–æŸä¼¤è°ƒæ§ä¸­çš„ç‹¬ç‰¹ä½œç”¨ [Mt2RNAseq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€leukemiaã€immuneã€immunityã€immunologyã€TMEã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€bioinformaticsã€R packageã€Bioconductorã€Seuratã€epigeneticã€epigenomeã€histoneã€enrichmentã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Zilun Wei ; Yongchao Zhao ; Aijun Sun ; Junbo GeSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusRNA undergoes various modifications in a manner similar to DNA, thereby opening up the research field of epitranscriptomics. Regulators of mRNA modifications play a role in many molecular processes, biological functions, and disease prognosis. Differential expression profile of RNA modification regulators from HFrEF patientsâ€™ hearts remains deficient at present, let alone their affections on the prognosis. A risk score model based on two modifications-related modulators (eIF3m and Nudt12) was built and screened out with a LASSO regression analysis. Translation dysregulation upon eIF3m knock down in cardiomyocytes was examined by combined high-throughput methods of transcriptome sequencing, ribosome profiling, proteome research, and Clip analyses. Metabolic assays and flux analysis were used to characterize the effects of eIF3m and its downstream mediator in metabolic reprogramming with high-level exogenous TNF-Î± to mimic a highly oxidative inflammatory injury. eIF3m deficiency leads to decoupling of the major steps in translation initiation and elongation. It stabilizes eIF3m-f-h subcomplex through proteasome dependent-polyubiquitination, and controls translational response of specific mRNAs. eIF3m directly binds to Mt2 5â€™ leader to upregulate its translation in NRCMs and H9c2 cells. eIF3m knockdown induced expression of genes involved in proinflammatory and oxidative stress, resulting in 3-NT modification to a key glycolysis enzyme Pfkfb3 when co-cultured with exogenous TNF-Î±. CM-specific eIF3m deletion deteriorates cardiac function and increases infarction size after I/R operation, whereas CM-specific eIF3m overexpression reverses the phenotype. Additionally, eIF3m overexpression inhibits whereas RNAi-mediated Mt2 knockdown activates NF-ÎºB signaling and aggravates nitrative damage. Metabolic analyses highlighted the role for eIF3m in promoting glycolysis and biosynthesis required for functional recovery of the myocardium. Our study demonstrates that the prognosis indicator eIF3m alleviates oxidative inflammatory injury and promotes glycolytic reprograming mainly by binding to Mt2 mRNA. Therapeutic strategies enhancing eIF3m level may possess therapeutic potential against I/R injury.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217285">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE217296 RNA ç»“åˆæ¨¡å¼æ­ç¤ºäº†ç¼ºè¡€æ€§å¿ƒåŠ›è¡°ç«­é¢„åæŒ‡æ ‡çœŸæ ¸ç¿»è¯‘èµ·å§‹å› å­ 3m åœ¨å¿ƒè‚Œç¼ºè¡€å†çŒæ³¨åç¡åŒ–æŸä¼¤è°ƒæ§ä¸­çš„ç‹¬ç‰¹ä½œç”¨ï¼Œæç¤ºå…¶åœ¨å¿ƒè‚Œç¼ºè¡€å†çŒæ³¨æŸä¼¤è°ƒæ§ä¸­å‘æŒ¥é‡è¦ä½œç”¨ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€leukemiaã€immuneã€immunityã€immunologyã€TMEã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNAseqã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€bioinformaticsã€R packageã€Bioconductorã€Seuratã€epigeneticã€epigenomeã€histoneã€enrichmentã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Homo sapiens ; Rattus norvegicusThis SuperSeries is composed of the SubSeries listed below.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217296">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE281368 THOC5 ä¾èµ–æ€§è½¬å½•åæ§åˆ¶ç»´æŒè¡€ç®¡å¹³æ»‘è‚Œç»†èƒç¨³æ€ï¼Œå¯¹æŠ—æ…¢æ€§è‚¾è„ç—…ç›¸å…³è¡€ç®¡é’™åŒ– [RIP-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€immuneã€TMEã€cardiacã€gliomaã€kinaseã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : OtherOrganism : Mus musculusBackground: Despite transcriptional control mechanisms of VSMC osteogenic transition having been extensively studied, posttranscriptional regulation is still awaiting elucidation. In the present study, we explore the mechanism of THOC5-dependent VSMCs osteochondrogenic switching. Methods: Von Kossa staining and immunohistochemistry staining were used to detect calcification and expression of THOC5 respectively. Thoc5 shRNA and Thoc5 overexpression lentivirus were used to modulate the expression of Thoc5. RNA-Seq combined with RIP-Seq was used to explore the target mRNAs that directly bind to THOC5, and FISH was used to confirm its subcellular localization. Results: Immunohistochemical staining showed significantly increased THOC5 expression in the calcified artery of CKD patients. Besides, calcification-induced increase of THOC5 expression was found in both in vivo and in vitro calcification models. The overexpression of Thoc5 relieves the calcification and osteogenic differentiation of VSMCs significantly in vitro, which is mainly manifested by the reduction of calcium ion deposition and the decreased expression of osteogenic markers. Furthermore, RNA-Seq revealed that THOC5 overexpression in osteogenic-induced VSMCs closely resembled the gene expression changes induced on TGF-Î² treatments in cultured VSMCs. In addition, overexpression of THOC5 alleviates the exacerbation of calcification in vivo. Our previous studies found that THOC5 displayed limited binding to VSMCs genomic DNA, so RIP-Seq was selected to detect target genes of THOC5. It was found that THOC5 directly interacts with Guanylate exchange factors (GEFs) mRNAs, and is required for their export. Thereby THOC5 maintaining RhoA GTPase activation contributes to increasing the expression of VSMCs contraction marker, which maintains the contraction phenotype of VSMCs. ROCK (Rho-kinase) inhibitor Y-27632 reversed the protective role of THOC5 on osteoblastic transdifferentiation and calcification, as well as the maintenance of the spindle morphology of VSMCs. Conclusions: Our data introduce the binding of THOC5 to GEFs as a novel mechanism contributing to maintaining VSMCs homeostasis and imply THOC5 as a potential intervention node for vascular calcification diseases.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281368">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE309106 å•ç»†èƒ RNA æµ‹åºæ­ç¤ºäº†èŠ³çƒƒå—ä½“æ¿€æ´»é€šè¿‡æ¶‰åŠè‚ºéƒ¨å…ç–«ç»†èƒå’Œä¸Šçš®ç»†èƒçš„å¤šæ¡é€šè·¯å‡è½»æ€¥æ€§å‘¼å¸çª˜è¿«ç»¼åˆå¾</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€immunityã€TMEã€cardiacã€gliomaã€resistanceã€TCGAã€sequencingã€RNAseqã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€transcriptomeã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€methylationã€histoneã€pathwayã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Mitzi NagarkattiSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAcute Respiratory Distress Syndrome (ARDS) is a severe inflammatory lung disorder triggered by pneumonia, sepsis, trauma, and COVID-19, leading to high mortality. In this study, we investigated the effect of Aryl Hydrocarbon Receptor (AhR) activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent ligand, on LPS-induced ARDS in mice using single-cell RNA sequencing (scRNA-seq). scRNA-seq revealed sixteen transcriptionally distinct cell clusters in the lungs. AhR activation reversed the decreased pulmonary functions caused by LPS, and significantly reduced pulmonary infiltration of monocytes, neutrophils, and macrophages. Interestingly, AhR activation during ARDS led to increased proportions of alveolar macrophages, and angiogenic and quiescent endothelial cells (AECs and QECs, respectively). Among the downregulated pathways, prostaglandin signaling was the most broadly suppressed across many cell types in the LPS+TCDD group. AhR activation suppressed the neutrophil chemotaxis pathway involving Cxcl2, Cxcl3, and Cxcl10. The damage to endothelial and epithelial cells induced during ARDS was also blocked by AhR activation. This was associated with decreased expression of S100a8 and S100a9. Notably, multiple pathways related to cellular junction organization were enriched following AhR activation. Additionally, Scgb1a1, also called Club cell protein 16 (CC16), primarily secreted by Club cells in the respiratory epithelium, was highly upregulated following AhR activation accounting for lung homeostasis. Together, these findings demonstrate that AhR activation mitigates key inflammatory and barrier-disruptive processes involving multiple cell types in LPS-induced ARDS. These data identify AhR as a central regulator of pulmonary inflammation and epithelialâ€“endothelial integrity and support the future evaluation of AhR-targeted therapeutics as potential treatment for ARDS.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309106">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE281115 THOC5 ä¾èµ–æ€§è½¬å½•åæ§åˆ¶ç»´æŒè¡€ç®¡å¹³æ»‘è‚Œç»†èƒç¨³æ€ï¼ŒæŠµæŠ—æ…¢æ€§è‚¾è„ç—…ç›¸å…³è¡€ç®¡é’™åŒ– [RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€immuneã€TMEã€cardiacã€gliomaã€kinaseã€TCGAã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€transcriptomeã€transcriptomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusBackground: Despite transcriptional control mechanisms of VSMC osteogenic transition having been extensively studied, posttranscriptional regulation is still awaiting elucidation. In the present study, we explore the mechanism of THOC5-dependent VSMCs osteochondrogenic switching. Methods: Von Kossa staining and immunohistochemistry staining were used to detect calcification and expression of THOC5 respectively. Thoc5 shRNA and Thoc5 overexpression lentivirus were used to modulate the expression of Thoc5. RNA-Seq combined with RIP-Seq was used to explore the target mRNAs that directly bind to THOC5, and FISH was used to confirm its subcellular localization. Results: Immunohistochemical staining showed significantly increased THOC5 expression in the calcified artery of CKD patients. Besides, calcification-induced increase of THOC5 expression was found in both in vivo and in vitro calcification models. The overexpression of Thoc5 relieves the calcification and osteogenic differentiation of VSMCs significantly in vitro, which is mainly manifested by the reduction of calcium ion deposition and the decreased expression of osteogenic markers. Furthermore, RNA-Seq revealed that THOC5 overexpression in osteogenic-induced VSMCs closely resembled the gene expression changes induced on TGF-Î² treatments in cultured VSMCs. In addition, overexpression of THOC5 alleviates the exacerbation of calcification in vivo. Our previous studies found that THOC5 displayed limited binding to VSMCs genomic DNA, so RIP-Seq was selected to detect target genes of THOC5. It was found that THOC5 directly interacts with Guanylate exchange factors (GEFs) mRNAs, and is required for their export. Thereby THOC5 maintaining RhoA GTPase activation contributes to increasing the expression of VSMCs contraction marker, which maintains the contraction phenotype of VSMCs. ROCK (Rho-kinase) inhibitor Y-27632 reversed the protective role of THOC5 on osteoblastic transdifferentiation and calcification, as well as the maintenance of the spindle morphology of VSMCs. Conclusions: Our data introduce the binding of THOC5 to GEFs as a novel mechanism contributing to maintaining VSMCs homeostasis and imply THOC5 as a potential intervention node for vascular calcification diseases.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281115">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE300680 äººç±»å•æ ¸ç»†èƒè¡ç”Ÿå·¨å™¬ç»†èƒçš„ç”Ÿæˆå’Œå¤šç»„å­¦åˆ†æçš„ç®€åŒ–å’Œç»¼åˆæ–¹æ¡ˆ [bulk RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€immuneã€TMEã€gliomaã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€epigeneticã€epigenomeã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Olivia G Palmer ; Laurent Perreard ; Fred W Kolling IV ; Patricia A Pioli ; Brittany A GoodsSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensMacrophages are versatile immune cells with phenotypes ranging from inflammatory (M1-like) to anti-inflammatory (M2-like), shaped by diverse differentiation and polarization conditions. We present a standardized protocol to generate and characterize human macrophages from frozen PBMC-derived monocytes using cytokine profiling, transcriptomics, and snRNA-seq, including depolarization studies. This streamlined approach facilitates reproducible macrophage studies from biobanked samples, advancing both research and therapeutic applications.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300680">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE293108 SKIDA1 åœ¨æ–°ç”Ÿå„¿æœŸçŸ­æš‚ç»´æŒ MLL::ENL è¡¨è¾¾çš„é€ è¡€ç¥–ç»†èƒï¼Œå¹¶ä¿ƒè¿› B ç»†èƒè°±ç³»å¯åŠ¨ [scRNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€lymphomaã€immuneã€TMEã€gliomaã€kinaseã€resistanceã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€Hi-Cã€scRNAã€scDNAã€scATACã€10xã€spatialã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€epigeneticã€epigenomeã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jonny Mendoza-Castrejon ; Jeffrey A MageeSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusTo assess changes in transcriptional responses to Skida1 deletion in the context of MLL::ENL, we performed CITE-seq on Tet-Off-ME mice.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293108">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 44 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ”¬ æœŸåˆŠæ–‡ç«  (7æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨7æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨7æ¡ï¼‰</h4><p><strong>1.</strong> <strong>äººé€ ç”œå‘³å‰‚åœ¨ç™Œç—‡å…ç–«æ²»ç–—ä¸­çš„è‹¦æ¶©å›å‘³</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡ã€å…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: æ‘˜è¦ï¼šMorderã€Nguyenã€Wilfahrt åŠå…¶åŒäº‹æŠ¥å‘Šè¯´ï¼Œéè¥å…»æ€§ç”œå‘³å‰‚é€šè¿‡æ¶‰åŠå¾®ç”Ÿç‰©ç¾¤å’Œä»£è°¢ç‰©è°ƒèŠ‚çš„æœºåˆ¶æŸå®³æŠ— PD-1 æ²»ç–—çš„ç–—æ•ˆã€‚ä»–ä»¬çš„ç ”ç©¶ç»“æœå¼ºè°ƒäº†å¤šç§ç™Œç—‡ç±»å‹é•¿æœŸç”Ÿæ´»æ–¹å¼å¹²é¢„çš„ä¸´åºŠç›¸å…³æ€§ï¼Œä¾‹å¦‚é™åˆ¶éè¥å…»æ€§ç”œå‘³å‰‚çš„æ¯æ—¥æ‘„å…¥é‡ã€‚å‚è§ Morder ç­‰äººçš„ç›¸å…³æ–‡ç« ï¼Œç¬¬ 2278 é¡µ</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1985400838140108800/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>äººç±»ç™Œç—‡å±æœºï¼šæŸ³å¶åˆ€è‚¿ç˜¤å­¦å§”å‘˜ä¼š</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: åœ¨è‚¿ç˜¤å­¦é¢†åŸŸå‰æ‰€æœªæœ‰çš„ç§‘å­¦è¿›æ­¥ä¸­ï¼Œè¶Šæ¥è¶Šå¤šçš„è¯æ®è¡¨æ˜ï¼Œäººç±»ç™Œç—‡æŠ¤ç†ç»å†ä¸­å­˜åœ¨ç€å¹³è¡Œè€Œæ·±åˆ»çš„å±æœºã€‚å°½ç®¡æ€»ä½“ç”Ÿå­˜ç»“æœæœ‰æ‰€æ”¹å–„ï¼Œä½†æ—¨åœ¨æä¾›æŠ¤ç†çš„ç³»ç»Ÿåœ¨è§£å†³ç™Œç—‡çš„æƒ…æ„Ÿã€å…³ç³»å’Œç”Ÿå­˜æ–¹é¢è¶Šæ¥è¶Šä¸è¶³ã€‚å°½ç®¡åœ¨æ¯ç§ç¯å¢ƒä¸­éƒ½å¯ä»¥æ‰¾åˆ°å¯Œæœ‰åŒæƒ…å¿ƒå’Œç»†å¿ƒæŠ¤ç†çš„ä¾‹å­ï¼Œä½†å…¨çƒèŒƒå›´å†…çš„æ‚£è€…å’Œå®¶å±ä»ç„¶æŠ¥å‘Šè¯´ï¼Œç”±äºä¼˜å…ˆè€ƒè™‘æŠ€æœ¯ç²¾ç¡®æ€§è€Œä¸æ˜¯äººç±»å­˜åœ¨çš„æŠ¤ç†ç»“æ„ï¼Œä»–ä»¬æ²¡æœ‰è¢«å€¾å¬ã€æ²¡æœ‰æ”¯æŒï¼Œæœ‰æ—¶ç”šè‡³å—åˆ°ç§¯æä¼¤å®³ã€‚æœ¬ã€Š æŸ³å¶åˆ€è‚¿ç˜¤å­¦å§”å‘˜ä¼šã€‹æå‡ºï¼Œäººç±»ç™Œç—‡å±æœºä¸æ˜¯ç”±ç—…ç†å­¦ã€æ­»äº¡ç‡æˆ–åŸå› å®šä¹‰çš„ï¼Œè€Œæ˜¯ç”±ç™Œç—‡ç»å†ä¸­æ„ä¹‰ã€è”ç³»å’ŒåŒæƒ…å¿ƒçš„ä¾µèš€æ¥å®šä¹‰çš„ã€‚è¿™åœºå±æœºæ˜¯ç”±å­˜åœ¨å’Œä¸å­˜åœ¨çš„ä¸œè¥¿å†³å®šçš„ï¼šæ”¯ç¦»ç ´ç¢ã€æ˜‚è´µå’Œç¼ºä¹ä¸ªäººåŒ–çš„ç³»ç»Ÿçš„å­˜åœ¨ï¼Œä»¥åŠäººé™…è”ç³»ã€å¿ƒç†å®‰å…¨å’Œå…³ç³»å…³æ€€çš„ç¼ºå¤±ã€‚è¿™æ˜¯ä¸€åœºæ¶µç›–åˆ†å¨©ã€å¿ƒç†å¥åº·ã€å§‘æ¯æ²»ç–—ã€ç ”ç©¶å’Œæ•™è‚²çš„å±æœºâ€”â€”è¿™åœºå±æœºä¸æ˜¯è‚¿ç˜¤å­¦è¿›æ­¥çš„è¾¹ç¼˜ï¼Œè€Œæ˜¯å…¶å¤±è´¥çš„æ ¸å¿ƒã€‚é‚£äº›å·²ç»å› ä¸å¹³ç­‰ã€æ­§è§†å’Œç»æµä¸ç¨³å®šè€Œå˜å¾—è„†å¼±çš„äººæ„Ÿå—åˆ°äº†è¿™åœºå±æœºçš„å½±å“æœ€ä¸ºå¼º</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1985482800108314624/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>åˆ©ç”¨å‰åˆ—è…ºç™Œä¸­çš„ AR ååŒä»£è°¢è„†å¼±æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å¯¹é›„æ¿€ç´ å‰¥å¤ºç–—æ³•çš„è€è¯æ€§ä»ç„¶æ˜¯å‰åˆ—è…ºç™Œçš„ä¸»è¦ä¸´åºŠæŒ‘æˆ˜ï¼Œéœ€è¦æ›¿ä»£æ²»ç–—ç­–ç•¥ã€‚é›„æ¿€ç´ å—ä½“ ï¼ˆARï¼‰ é€šè¿‡å¢å¼º AR ä¿¡å·ä¼ å¯¼ã€DNA ä¿®å¤å’Œè‡ªå™¬ç­‰æœºåˆ¶åœ¨é©±åŠ¨è€è¯æ€§æ–¹é¢å‘æŒ¥æ ¸å¿ƒä½œç”¨ã€‚åœ¨æœ¬æœŸã€Šç™Œç—‡ç ”ç©¶ã€‹ä¸­ï¼ŒCordova åŠå…¶åŒäº‹å‘ç°äº† AR è›‹ç™½åˆæˆä¸­çš„ä»£è°¢è„†å¼±æ€§ï¼Œè¡¨æ˜éš”æ—¥ç¦é£Ÿ ï¼ˆADFï¼‰ é€šè¿‡è¯±å¯¼ AR mRNA ä¸Šçš„æ ¸ç³–ä½“ç¢°æ’æ¥æŸå®³ AR ç¿»è¯‘ã€‚è¿™ç§åº”æ¿€ååº”æ¿€æ´»æ¿€é…¶ï¼Œä¾‹å¦‚ p38 MAPKï¼Œå¹¶é€‰æ‹©æ€§åœ°é™ä½ AR è›‹ç™½æ°´å¹³ï¼Œä¸è½¬å½•æˆ–è›‹ç™½è´¨ç¨³å®šæ€§æ— å…³ã€‚å€¼å¾—æ³¨æ„çš„æ˜¯ï¼ŒADF å¢å¼ºäº†æ©æ‚é²èƒºåœ¨å¤šç§å‰åˆ—è…ºç™Œæ¨¡å‹ä¸­çš„ç–—æ•ˆã€‚ä¸ä¼ ç»Ÿçš„ AR é¶å‘æ–¹æ³•ä¸åŒï¼ŒADF æ­ç¤ºäº†è¥å…»èƒè¿«ä¸‹ AR è¡¨è¾¾çš„è½¬å½•åä¾èµ–æ€§ï¼ŒåŒæ—¶ä¿ç•™äº†å¤§å¤šæ•°å…¶ä»–è›‹ç™½è´¨ã€‚è¿™äº›å‘ç°å‡¸æ˜¾äº†å‰åˆ—è…ºç™Œä¸­ä¸€ç§æ–°çš„è½¬åŒ–è„†å¼±æ€§ï¼Œå¹¶æ”¯æŒå°†é¥®é£Ÿå¹²é¢„ä¸ AR é¶å‘ç–—æ³•ç›¸ç»“åˆï¼Œä»¥å…‹æœè€è¯æ€§å¹¶æ”¹å–„æ‚£è€…çš„é¢„åã€‚å‚è§ Cordova ç­‰äººçš„ç›¸å…³æ–‡ç« ï¼Œç¬¬ 4182 é¡µ</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1985400849754136576/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>GLP-1 æ¿€åŠ¨å‰‚ä¼šå‰Šå¼±è‚¥èƒ–ä¸ç™Œç—‡ä¹‹é—´çš„è”ç³»å—ï¼Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: æ‘˜è¦ï¼šèƒ°é«˜è¡€ç³–ç´ æ ·è‚½1å—ä½“æ¿€åŠ¨å‰‚åœ¨é€†è½¬è‚¥èƒ–ç—‡æ‚£è€…çš„ä¸€äº›ç™Œç—‡é£é™©æ–¹é¢æœ‰å¾ˆå¤§çš„å¸Œæœ›ï¼Œåˆ°ç›®å‰ä¸ºæ­¢ï¼Œæ–°å…´çš„ä¸´åºŠè¯•éªŒæ”¯æŒè¿™ä¸€ç‚¹ã€‚ç„¶è€Œï¼Œä¸€äº›ä¸´åºŠå‰å·¥ä½œå’Œäººä½“ç ”ç©¶çš„è­¦å‘Šå¼ºè°ƒï¼Œéœ€è¦æ›´å¤šçš„å·¥ä½œæ¥äº†è§£æŠ—è‚¥èƒ–è¯ç‰©åœ¨ç™Œç—‡ä¸­çš„æœºåˆ¶å’Œå…¨éƒ¨æ½œåŠ›ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1985400844523839488/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>ä»åˆ›æ–°åˆ°å½±å“åŠ›ï¼šå…±åŒæ¨è¿›ç™Œç—‡ç ”ç©¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: æ‘˜è¦ï¼šç™Œç—‡ç ”ç©¶å·²è¿›å…¥ä¸€ä¸ªå˜é©æ—¶ä»£ï¼Œå…¶ç‰¹ç‚¹æ˜¯å…ç–«ç–—æ³•ã€æ—©æœŸæ£€æµ‹ã€ç²¾å‡†è‚¿ç˜¤å­¦å’Œäººå·¥æ™ºèƒ½çš„å¿«é€Ÿè¿›æ­¥æ­£åœ¨é‡å¡‘é¢„é˜²ã€æ²»ç–—å’Œç”Ÿå­˜ç‡ã€‚ä¸ºäº†ä¿æŒåŠ¿å¤´ï¼Œå…¨çƒç™Œç—‡ç•Œå¿…é¡»å›´ç»•æŠ•èµ„ã€åˆä½œå’Œå…¬å¹³å›¢ç»“èµ·æ¥ï¼Œä»¥ç¡®ä¿æ¯ä½æ‚£è€…éƒ½èƒ½ä»è¿™äº›çªç ´ä¸­å—ç›Šã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1985400861754040320/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>è‚ºå†…çš® PEAR1 è¯±å¯¼è‚¿ç˜¤ç»†èƒä¼‘çœ </strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: åœ¨è®¸å¤šç™Œç—‡æ‚£è€…ä¸­ï¼Œè¿œå¤„è½¬ç§»æ˜¯åœ¨å¤šå¹´çš„ä¼‘çœ åå‘å±•èµ·æ¥çš„ã€‚äº†è§£é€šå¸¸åœ¨å¾®è¡€ç®¡ç³»ç»Ÿé™„è¿‘å‘ç°çš„æ’­æ•£æ€§è‚¿ç˜¤ç»†èƒ ï¼ˆDTCï¼‰ å¦‚ä½•ä¿æŒä¼‘çœ çŠ¶æ€ä»¥åŠè°ƒèŠ‚å…¶é‡æ–°æ¿€æ´»çš„å› ç´ æ˜¯è‚¿ç˜¤ç”Ÿç‰©å­¦çš„ä¸»è¦æŒ‘æˆ˜ä¹‹ä¸€ã€‚åœ¨ç­›é€‰èƒ½å¤Ÿè°ƒèŠ‚è‚¿ç˜¤ç»†èƒä¼‘çœ çš„å†…çš®åˆ†æ³Œè›‹ç™½å’Œè´¨è†œè›‹ç™½æ—¶ï¼Œæˆ‘ä»¬é‰´å®šäº†è·¨è†œè›‹ç™½è¡€å°æ¿å’Œå†…çš®èšé›†å—ä½“ 1 ï¼ˆPEAR1ï¼‰ã€‚ç¼ºä¹ PEAR1 çš„äººå’Œå°é¼ å†…çš®ç»†èƒå¤±å»äº†ä¿ƒè¿›ä¸åŒè‚¿ç˜¤ç»†èƒä¼‘çœ çš„èƒ½åŠ›ï¼ŒPEAR1 çš„ç»†èƒå¤–éƒ¨åˆ†èƒ½å¤ŸæŒ½æ•‘è¿™ç§ä½œç”¨ã€‚åŒæ ·ï¼Œåœ¨å†…çš®ç»†èƒä¸­ç¼ºä¹ PEAR1 çš„å°é¼ ä¸­ï¼Œè‚ºéƒ¨è‚¿ç˜¤ç»†èƒä¼‘çœ å‡å°‘ï¼Œè‚¿ç˜¤è½¬ç§»å¢åŠ ã€‚æˆ‘ä»¬å‘ç° PEAR1 é€šè¿‡ç»“åˆèµ–æ°¨é…°æ°§åŒ–é…¶æ · 2ï¼ˆLOXL2ï¼‰å’Œç»„ç»‡è›‹ç™½é…¶ Dï¼ˆCTSDï¼‰æ¥è¯±å¯¼è‚¿ç˜¤ç»†èƒä¼‘çœ ï¼Œè¿™æ—¢èƒ½æŠ‘åˆ¶è‚¿ç˜¤ç»†èƒä¼‘çœ ï¼Œåˆèƒ½ä¿ƒè¿›è‚¿ç˜¤ç”Ÿé•¿å’Œè½¬ç§»ã€‚CTSD è¡¨è¾¾å—åˆ°æŠ‘åˆ¶çš„è‚¿ç˜¤ç»†èƒåœ¨ä½“å†…è¡¨ç°å‡ºä¼‘çœ å¢åŠ å’Œè½¬ç§»æ½œåŠ›é™ä½ã€‚æˆ‘ä»¬çš„æ•°æ®ç¡®å®šäº†è‚¿ç˜¤ç»†èƒä¼‘çœ çš„æ½œåœ¨æœºåˆ¶ï¼Œå¹¶å»ºè®®å°† CTSD å’Œ LOXL2 ä½œä¸ºä¿ƒè¿›ä¼‘çœ çš„æ–¹æ³•çš„é¶ç‚¹ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1985427732881383424/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>æŠ—ä½“-è¯ç‰©å¶è”ç‰©åœ¨ç™Œç—‡æ²»ç–—ä¸­çš„åº”ç”¨ï¼šç°çŠ¶ã€æŒ‘æˆ˜å’Œæœªæ¥æ–¹å‘</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: æŠ—ä½“-è¯ç‰©å¶è”ç‰© ï¼ˆADCï¼‰ å·²æˆä¸ºè‚¿ç˜¤å­¦ä¸­çš„ä¸€ç§å˜é©æ€§æ¨¡å¼ï¼Œå®ƒå°†æŠ—ä½“çš„é¶æ ‡ç‰¹å¼‚æ€§ä¸å¤šç§ç»†èƒæ¯’æ€§æœ‰æ•ˆè½½è·çš„é«˜æ•ˆç›¸ç»“åˆã€‚æœ¬ç»¼è¿°æä¾›äº†ä»åˆ†å­è®¾è®¡åˆ°ä¸´åºŠè½¬åŒ–çš„ ADC çš„ç»¼åˆæ¦‚è¿°ã€‚æˆ‘ä»¬å‰–æäº†ç»“æ„æˆåˆ†ã€æŠ—ä½“ã€æ¥å¤´å’Œæœ‰æ•ˆè½½è·ï¼Œå¹¶é˜æ˜äº†å®ƒä»¬å¯¹è¯ä»£åŠ¨åŠ›å­¦ã€è‚¿ç˜¤é€‰æ‹©æ€§å’Œæ²»ç–—æŒ‡æ•°çš„å½±å“ã€‚å¼ºè°ƒäº†åŒ…æ‹¬æŠ—åŸè¯†åˆ«ã€å—ä½“ä»‹å¯¼çš„å†…åŒ–ã€æœ‰æ•ˆè½½è·é‡Šæ”¾å’Œå…ç–«åŸæ€§ç»†èƒæ­»äº¡ ï¼ˆICDï¼‰ åœ¨å†…çš„æœºåˆ¶é€”å¾„ï¼Œä¸º ADC åŠŸèƒ½æä¾›èƒŒæ™¯ä¿¡æ¯ã€‚åœ¨ä¸´åºŠä¸Šï¼ŒADC å·²è¯æ˜å¯¹è¡€æ¶²ç³»ç»Ÿå’Œå®ä½“æ¶æ€§è‚¿ç˜¤å…·æœ‰ç–—æ•ˆï¼Œå·²è·å¾— 15 é¡¹ç¾å›½é£Ÿå“å’Œè¯ç‰©ç®¡ç†å±€ ï¼ˆFDAï¼‰ æ‰¹å‡†ï¼Œå¹¶ä¸æ–­æ‰©å¤§ç ”ç©¶ç®¡é“ã€‚ç„¶è€Œï¼ŒæŒ‘æˆ˜ä¾ç„¶å­˜åœ¨ï¼ŒåŒ…æ‹¬æŠ—åŸå¼‚è´¨æ€§ã€è€è¯æœºåˆ¶ã€å…¨èº«æ¯’æ€§å’Œåˆ¶é€ å¤æ‚æ€§ã€‚åŒç‰¹å¼‚æ€§ ADCã€å…ç–«åˆºæ¿€æœ‰æ•ˆè½½è·ã€äººå·¥æ™ºèƒ½å¼•å¯¼è®¾è®¡å’Œçº³ç±³æŠ€æœ¯å¢å¼ºé€’é€ç­‰æ–°å…´åˆ›æ–°æ­£åœ¨é‡å¡‘ ADC æ ¼å±€ã€‚æœ€åï¼Œæˆ‘ä»¬å¼ºè°ƒäº†è¯Šæ–­ç²¾åº¦å’Œåˆç†ç»„åˆç­–ç•¥çš„å¿…è¦æ€§ï¼ŒåŒæ—¶å¼ºè°ƒäº†å…±åŒå¡‘é€ ä¸‹ä¸€ä»£ ADC ç–—æ³•æœªæ¥æ–¹å‘çš„æ–°å…´åˆ›æ–°ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1985427733527306240/t>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (2æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨2æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4><p><strong>1.</strong> <strong>R Shiny ä¸­çš„è¡Œä¸ºé©±åŠ¨å¼€å‘ï¼šä½¿ç”¨ç»™å®šæ­¥éª¤è®¾ç½®æµ‹è¯•å‰ææ¡ä»¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šHi-Cã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šLearn how to set up test preconditions in Shiny BDD using Given steps. Master dependency injection, test doubles, and composable setup patterns for reliable R testing. Continue reading: Behavior-Driven Development in R Shiny: Setting Up Test Preconditions with Given Steps</li><li>ğŸ”— <a href=https://www.r-bloggers.com/2025/11/behavior-driven-development-in-r-shiny-setting-up-test-preconditions-with-given-steps/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>Maestro 0.7.0 å¼•å…¥äº†æ¡ä»¶ç®¡é“</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscDNA</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šThe 0.7.0 release of maestro is out, and with it is the ability to conditionally run pipelines. In a nutshell, this is especially useful when you have DAG pipelines and you want to branch or only execute parts of a DAG when the output meets a pa&mldr; Continue reading: maestro 0.7.0 introduces conditional pipelines</li><li>ğŸ”— <a href=https://www.r-bloggers.com/2025/11/maestro-0-7-0-introduces-conditional-pipelines/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨3æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>åˆ©ç”¨å•ç»†èƒRNAæµ‹åºè§£ç è‚¾ç™Œä¸­çš„å¹²æ‰°ç´ ä¿¡å·é€šè·¯</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€kinaseã€TCGAã€sequencingã€RNA-seqã€RNAseqã€DNA-seqã€Hi-Cã€single.cellã€single-cellã€scRNAã€scATAC</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSingle-cell RNA sequencing reveals how interferon signaling in macrophages drives resistance to immunotherapy in renal cell carcinoma, offering new insights for biomarker discovery and treatment strategies&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/decoding-interferon-signaling-in-kidney-cancer-with-single-cell-rna-sequencing/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>isoLASERé•¿è¯»é•¿RNAæµ‹åºå¯åŒºåˆ†é¡ºå¼å’Œåå¼å®šå‘çš„RNAé€‰æ‹©æ€§å‰ªæ¥</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€cardiacã€resistanceã€RNA-seqã€RNAseqã€DNA-seqã€scRNAã€scDNAã€scATAC</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing using long-read technology reveals how cis- and trans-acting elements control splicing in disease-related genes including MAPT and BIN1&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/isolaser-long-read-rna-seq-demarcates-cis-and-trans-directed-alternative-rna-splicing/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>ä»å®éªŒå®¤åˆ°ç”Ÿç‰©ä¿¡æ¯å­¦ï¼šæ„å»ºä¸‹ä¸€ä»£åŸºå› æµ‹åºç½‘ç»œ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€kinaseã€TCGAã€sequencingã€RNAseqã€bioinformaticsã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing advances are empowering veterinary diagnosticians to detect emerging pathogens faster and improve animal health surveillance through hands-on training in next-generation sequencing and bioinformatics&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/from-bench-to-bioinformatics-networking-the-next-generation-in-genetic-sequencing/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>TME</td><td>51</td></tr><tr><td>scRNA</td><td>47</td></tr><tr><td>genome</td><td>46</td></tr><tr><td>scATAC</td><td>41</td></tr><tr><td>scDNA</td><td>39</td></tr><tr><td>Seurat</td><td>39</td></tr><tr><td>genomics</td><td>39</td></tr><tr><td>cancer</td><td>37</td></tr><tr><td>glioma</td><td>37</td></tr><tr><td>TCGA</td><td>34</td></tr><tr><td>histone</td><td>34</td></tr><tr><td>spatial</td><td>31</td></tr><tr><td>RNAseq</td><td>29</td></tr><tr><td>tumor</td><td>29</td></tr><tr><td>proteome</td><td>25</td></tr><tr><td>RNA-seq</td><td>24</td></tr><tr><td>single.cell</td><td>23</td></tr><tr><td>carcinoma</td><td>22</td></tr><tr><td>immune</td><td>22</td></tr><tr><td>kinase</td><td>20</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-å…¬ä¼—å·></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (16æ¡)</summary><div class=details-content markdown=1><ul><li><a href="https://mp.weixin.qq.com/s?__biz=MzkzNzY2NDgyOQ==&amp;mid=2247493101&amp;idx=1&amp;sn=ceef86351c934a18781ac3fdc7ac937d">metaforåŒ…:é€‰æ‹©æ¨¡å‹ï¼ˆSelection Modelsï¼‰</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzAxMDkxODM1Ng==&amp;mid=2247546635&amp;idx=1&amp;sn=8a9fbdb461f7c704e07e61f054b3e200">Nature Geneticsæ‚å¿—ç‰¹åˆ«ç‰ˆå•ç»†èƒmarkeråŸºå› æ°”æ³¡å›¾</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523355&amp;idx=1&amp;sn=60fbf5c6d57fa27881e17041c1eddd6f">10+åªéœ€è¦å…¨è½¬å½•ç»„å…³è”ç ”ç©¶TWAS+å•ç»†èƒ+æœºå™¨å­¦ä¹ ~å¿«æ¥å›´è§‚æ€è·¯å§ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649462&amp;idx=2&amp;sn=faa16e80dcf2ba783285ffb449f172d0">ä»å¤šç»´åˆ†æåˆ°ç©ºé—´éªŒè¯ï¼šæ„å»ºè‚¿ç˜¤å…ç–«ç ”ç©¶å®Œæ•´æ€è·¯ï¼ˆæœ‰å¥–ç›´æ’­ï¼‰</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMzI5MDU0Mg==&amp;mid=2247485380&amp;idx=2&amp;sn=5d41f7d3d658b0b24d2699b1654ec019">ä»é›¶äº†è§£ç©ºé—´è½¬å½•ç»„ç»†èƒé€šè®¯(äºŒ)</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMzI5MDU0Mg==&amp;mid=2247485380&amp;idx=1&amp;sn=09ae45c6c37a33a3c3ab65b1362a75cd">ä»é›¶äº†è§£ç©ºé—´è½¬å½•ç»„ç»†èƒé€šè®¯(ä¸€)</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg5MDk3Mzg4OA==&amp;mid=2247498404&amp;idx=1&amp;sn=d6615b113ae6d19bc0137f3cbfe0ed10">åˆ°ç°åœ¨è¿˜ä¸ä¼šç”¨ggforceåŒ…ï¼Ÿä¸‰åˆ†é’Ÿå¸¦ä½ ç©è½¬é«˜çº§æ•°æ®å¯è§†åŒ–ï¼Œè®©ä½ çš„å›¾è¡¨ç¬é—´é«˜å¤§ä¸Šï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495414&amp;idx=1&amp;sn=80a30c4ee87a6a6bb2bf379eafbb6847">å†¬å¤©åˆ°äº†ï¼Œç©ºè°ƒç”µè´¹çœäº†ï¼Œç»™å¤§å®¶åšç‚¹æœåŠ¡å™¨åŒ 11 æ´»åŠ¨ï¼Œä¾¿æ·å¼ç”Ÿä¿¡äº‘æœåŠ¡å™¨</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2MDY1NTYyOQ==&amp;mid=2247498718&amp;idx=1&amp;sn=c00f20918538cdfaaabb57ba77e9334d">è„šæœ¬æ›´æ–°&ndash;visiumæ•°æ®çš„å¤šæ ·æœ¬å…±å®šä½ä¸åˆ†ç»„å·®å¼‚åˆ†æ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg2NTE1MzU4NQ==&amp;mid=2247523345&amp;idx=1&amp;sn=1ce6d118f6a7e4ab54ac97307cfe6612">åŸºå› é€‰æ‹©ä¸å†éš¾ï¼GeneSelectRï¼šä¸€é”®å®Œæˆå¤šæ–¹æ³•ç‰¹å¾é€‰æ‹©ä¸å¯Œé›†åˆ†æ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247656902&amp;idx=2&amp;sn=6598ddea37dc7c05152e76cdab17eed8">Cell Pressä¸æ‚¨ç›¸çº¦ç¬¬åä¸ƒå±Šå…¨å›½å…ç–«å­¦å¤§ä¼šï¼| 11æœˆ7æ—¥15ç‚¹ï¼Œç¼–è¾‘è§é¢ä¼šä¸è§ä¸æ•£</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247656902&amp;idx=1&amp;sn=3a82c506eebfbac401f722a170d07dd7">è°­è”šæ³“/å´èŠ©Cell Biomatï¼šç»ˆç»“â€œå†·è‚¿ç˜¤â€ï¼CD4+Tç»†èƒååŒæŠ‘åˆ¶ä¸‰é˜´æ€§ä¹³è…ºç™Œ | Cell Presså¯¹è¯ç§‘å­¦å®¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMzI5MDU0Mg==&amp;mid=2247485264&amp;idx=1&amp;sn=a999b3d6ee2607b76b7afed9c5b88876">å•ç»†èƒå¯è§†åŒ–è¿›é˜¶-Dotplot</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMzI5MDU0Mg==&amp;mid=2247485397&amp;idx=1&amp;sn=96ac9c8ccd37a2ec60bcd96b357ac3e0">å•ç»†èƒRo/e (ROE)è®¡ç®—åŠæ£’æ£’ç³–lollipopå›¾ç»˜åˆ¶</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMzI5MDU0Mg==&amp;mid=2247485547&amp;idx=1&amp;sn=9b354717886e2847ef4b09bc5d3ff258">å•ç»†èƒå¯è§†åŒ–è¿›é˜¶â€”â€”æŒ‡å®šç»†èƒç±»å‹å¯†åº¦å›¾</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMzI5MDU0Mg==&amp;mid=2247485587&amp;idx=1&amp;sn=49cd1249b988ac41f451204d1fef579f">å•ç»†èƒå¯è§†åŒ–è¿›é˜¶â€”â€”æŒ‡å®šç»†èƒç±»å‹å¯†åº¦å›¾[æ›´æ–°]</a></li></ul></div></details><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (44æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305252">GSE305252 ä¹³é…°-HDAC1ä»‹å¯¼çš„è¡¨è§‚é—ä¼ é—¨æ§é€šè¿‡ä»£è°¢é‡ç¼–ç¨‹è°ƒæ§è¡€ç®¡ç”Ÿæˆè½¬å½•[ChIP-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299661">GSE299661 ORB2 RNAç»“åˆè›‹ç™½é€šè¿‡å…¶åŠŸèƒ½ä¿å®ˆçš„é”Œç»“åˆâ€œZZâ€ç»“æ„åŸŸï¼Œåœ¨æœè‡æ¯ä½“å‘åˆå­è½¬å˜è¿‡ç¨‹ä¸­æŠ‘åˆ¶å…¶é¶è½¬å½•æœ¬çš„ç¿»è¯‘ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299140">GSE299140 æœè‡æ¯æºå‘åˆå­è½¬å˜è¿‡ç¨‹ä¸­ï¼ŒORB2 RNAç»“åˆè›‹ç™½é€šè¿‡å…¶åŠŸèƒ½ä¿å®ˆçš„é”Œç»“åˆâ€œZZâ€ç»“æ„åŸŸæŠ‘åˆ¶é¶è½¬å½•æœ¬çš„ç¿»è¯‘ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299109">GSE299109 æœè‡æ¯æºå‘åˆå­è½¬å˜è¿‡ç¨‹ä¸­ï¼ŒORB2 RNAç»“åˆè›‹ç™½é€šè¿‡å…¶åŠŸèƒ½ä¿å®ˆçš„é”Œç»“åˆâ€œZZâ€ç»“æ„åŸŸæŠ‘åˆ¶é¶è½¬å½•æœ¬çš„ç¿»è¯‘ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305251">GSE305251 ä¹³é…°-HDAC1ä»‹å¯¼çš„è¡¨è§‚é—ä¼ é—¨æ§é€šè¿‡ä»£è°¢é‡ç¼–ç¨‹è°ƒæ§è¡€ç®¡ç”Ÿæˆè½¬å½•[RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293173">GSE293173 HIV å¯¹ Mtb/SIV å…±æ„ŸæŸ“æ’æ²³çŒ´æ¨¡å‹ä¸­æ½œä¼æ€§ç»“æ ¸æ„ŸæŸ“å½±å“çš„å•ç»†èƒè½¬å½•ç»„å­¦ç ”ç©¶ [scRNA-seq cART+3HP]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268719">GSE268719 å…ˆé”‹è½¬å½•å› å­ä¹‹é—´çš„åˆ†å­å’Œä¸Šä½æ€§ç›¸äº’ä½œç”¨å¡‘é€ æ ¸å°ä½“åŠ¨åŠ›å­¦å’Œç»†èƒåˆ†åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291137">GSE291137 è½¬å½•ç»„å­¦æ­ç¤ºäº†èœ±è™« Ixodes ricinus ä¸­è‚ è›‹ç™½é‡‘å±è›‹ç™½é…¶å’ŒæŠ—åŸ p23 çš„åŠŸèƒ½ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300681">GSE300681 äººç±»å•æ ¸ç»†èƒè¡ç”Ÿå·¨å™¬ç»†èƒçš„ç”Ÿæˆå’Œå¤šç»„å­¦åˆ†æçš„ç®€åŒ–å’Œç»¼åˆæ–¹æ¡ˆ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293107">GSE293107 SKIDA1 åœ¨æ–°ç”Ÿå„¿æœŸçŸ­æš‚ç»´æŒ MLL::ENL è¡¨è¾¾çš„é€ è¡€ç¥–ç»†èƒï¼Œå¹¶ä¿ƒè¿› B ç»†èƒè°±ç³»å¯åŠ¨ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309745">GSE309745 åˆ©ç”¨å°é¼ æ¨¡å‹å’Œäººè‚ºç»„ç»‡çš„å•ç»†èƒå’Œå•æ ¸è½¬å½•ç»„åˆ†æç ”ç©¶è‚ºçº¤ç»´åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309471">GSE309471 åšæ¥éœ‰ç´ è¯±å¯¼å’Œå¼ºåŠ›éœ‰ç´ è¯±å¯¼çš„TGF-Î²è½¬åŸºå› å°é¼ è‚ºçº¤ç»´åŒ–æ¨¡å‹è‚ºç»†èƒçš„å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303777">GSE303777 ç—£æºæ€§é»‘ç´ ç»†èƒåŠå…¶åŒ¹é…çš„ç—…ç¶å‘¨å›´çš®è‚¤é»‘ç´ ç»†èƒçš„å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281161">GSE281161 ä¸€é¡¹ CDK9 æŠ‘åˆ¶å‰‚ voruciclib æ²»ç–—å¤å‘/éš¾æ²»æ€§æ€¥æ€§é«“ç³»ç™½è¡€ç—…å’Œ B ç»†èƒæ¶æ€§è‚¿ç˜¤çš„ 1 æœŸç ”ç©¶</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291941">GSE291941 ç¼ºæ°§æ¡ä»¶ä¸‹ç›˜åŸºç½‘æŸ„èŒåŸºå› è¡¨è¾¾å˜åŒ–çš„å…¨å±€ç‰¹å¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302849">GSE302849 å‰ç²’è›‹ç™½é€šè¿‡ä½œç”¨äºæ˜Ÿå½¢èƒ¶è´¨ç»†èƒä¿ƒè¿›æµ·é©¬ç¥ç»å…ƒçš„æ ‘çªç”Ÿé•¿</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302070">GSE302070 Treg å¯¹ç™½ç»†èƒä»‹ç´ -2 ååº”çš„å¼‚è´¨æ€§å’ŒåŒè´¨æ€§ [RNAseq2ï¼šIL2 å…ç–«ç»†èƒå› å­å¯¹å…ç–«ç»†èƒç±»å‹çš„å·®å¼‚æ€§æ¿€æ´»]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309373">GSE309373 æ­£å¸¸äººè‚ºç»„ç»‡ç¦»ä½“ç²¾ç¡®åˆ‡å‰²è‚ºåˆ‡ç‰‡çš„å•æ ¸RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217257">GSE217257 è‘¡è„ç³–ä»£è°¢é€šè¿‡CCN1å½±å“éª¨ç»†èƒå¯¹æœºæ¢°åˆºæ¿€çš„é€‚åº”æ€§ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277340">GSE277340è½¬å½•ç»„åˆ†ææ­ç¤ºäº†Hedgehogä¿¡å·é€šè·¯ä½œä¸ºç”Ÿç‰©æ ‡å¿—ç‰©åœ¨æ¢…å†…ç‰¹é‡Œå°”ç—…å‘ç—…æœºåˆ¶ä¸­çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296838">GSE296838 å¤šè¥¿ä»–èµ›æ²»ç–—é€šè¿‡æ¿€æ´»èŠ±ç”Ÿå››çƒ¯é…¸é€šè·¯ä¸Šè°ƒä¸‰é˜´æ€§ä¹³è…ºç™Œç»†èƒä¸­é›Œæ¿€ç´ å—ä½“çš„è¡¨è¾¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299316">GSE299316 Treg å¯¹ç™½ç»†èƒä»‹ç´ -2 ååº”çš„å¼‚è´¨æ€§å’ŒåŒè´¨æ€§ [scATAC-seq1: IL2 2h å’Œ PBS Ctl]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268543">GSE268543 ä¸€é¡¹æ¯”è¾ƒè½¬å½•ç»„åˆ†æä¸ºé¦™è•‰é±¼è›‡çš„ç”Ÿæ€é€‚åº”æ€§æä¾›äº†æ–°çš„è§è§£</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272769">GSE272769 å…¨è¡€è½¬å½•ç»„åˆ†æé‰´å®šå‡ºè„“æ¯’ç—‡æ­»äº¡ç‡çš„è¡¨è¾¾ç‰¹å¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301342">GSE301342 Treg å¯¹ç™½ç»†èƒä»‹ç´ -2 ååº”çš„å¼‚è´¨æ€§å’ŒåŒè´¨æ€§ [scRNA-seq: IL2/JES6-1 æ—¶é—´åºåˆ—]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299361">GSE299361 Treg å¯¹ç™½ç»†èƒä»‹ç´ -2 ååº”çš„å¼‚è´¨æ€§å’ŒåŒè´¨æ€§ [scATAC-seq2: IL2/JES6-1 æ—¶é—´è¿›ç¨‹]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297939">GSE297939 ç»˜åˆ¶ ER é˜³æ€§ä¹³è…ºç™Œå¯¹å¸•åšè¥¿å°¼çš„å¤šå±‚æ¬¡åˆ†å­ååº”å›¾è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73606">GSE73606 ä½å‰‚é‡æŠ—é›„æ¿€ç´ ç‰©è´¨å¯¹Wistarå¤§é¼ ç¾ä¸¸çš„å½±å“[è½¬å½•ç»„åˆ†æ]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279769">GSE279769 åˆ©ç”¨é…ä½“åŠŸèƒ½åŒ–çš„ CRISPR-Cas9 å¯¹å•ä¸ª G-å››é“¾ä½“è¿›è¡Œé¶å‘ï¼Œæ­ç¤ºäº†è½¬å½•ä¾èµ–æ€§åŠŸèƒ½ååº”ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292707">GSE292707 UGT2B17çš„éç»å…¸åŠŸèƒ½ä¿ƒè¿›å»åŠ¿æŠµæŠ—æ€§å‰åˆ—è…ºç™Œçš„è¿›å±•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303687">GSE303687 ChAT-eGFP+è„‚è‚ªåŸºè´¨è¡€ç®¡ç»†èƒçš„å•ç»†èƒRNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217623">GSE217623 æ–‘é©¬é±¼é€‚ç”¨è›‹ç™½è´¨æ•°æ®åº“æ„å»ºçš„è›‹ç™½è´¨åŸºå› ç»„å­¦ç­–ç•¥æ¯”è¾ƒ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217269">GSE217269 é‡ç”Ÿå‹ (WT) å’Œ Mettl3-/- (KO) BMDMï¼ˆéª¨é«“æ¥æºå·¨å™¬ç»†èƒï¼‰è½¬å½•ç»„çš„ RNA-seq åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296893">GSE296893 ç ”ç©¶å‘ç°ï¼Œæ¥å—æŠ—é€†è½¬å½•ç—…æ¯’æ²»ç–—çš„ HIV æ„ŸæŸ“è€…ä¸­ï¼ŒæŒç»­å­˜åœ¨çš„è‚ºç‚çƒèŒå®šæ¤ä¸é¼»è…”ç‚ç—‡ç›¸å…³ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296240">GSE296240 Treg å¯¹ç™½ç»†èƒä»‹ç´ -2 ååº”çš„å¼‚è´¨æ€§å’ŒåŒè´¨æ€§ [RNAseq1: IL2/JES6-1 æ—¶é—´åºåˆ—]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306285">GSE306285 ä¸åŒçš„ç™½è¡€ç—…çªå˜åœ¨æ ¸ç›¸åˆ†ç¦»å‡èšä½“ä¸­æ±‡èš</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307517">GSE307517 ClinASOï¼šé—´éš™åä¹‰å¯¡æ ¸è‹·é…¸å¿«é€Ÿè¯ç‰©å‘ç°æŒ‡å—</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73605">GSE73605 ä½å‰‚é‡æŠ—é›„æ¿€ç´ ç‰©è´¨å¯¹Wistarå¤§é¼ ç¾ä¸¸çš„å½±å“[miRNomeåˆ†æ]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292424">GSE292424 EGFæ¿€æ´»POMCåŸºå› è½¬å½•æ˜¯é€šè¿‡STAT3ä»‹å¯¼çš„ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281062">GSE281062ç”²åŸºåŒ–èŠ¯ç‰‡ä¿¡å·æ— éœ€äºšç¡«é…¸æ°¢ç›è½¬åŒ–å³å¯é¢„æµ‹å®é™…å¹´é¾„</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73607">GSE73607 ä½å‰‚é‡æŠ—é›„æ¿€ç´ ç‰©è´¨å¯¹Wistarå¤§é¼ ç¾ä¸¸çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217338">GSE217338 äººç±»å¿ƒè„ç»„ç»‡å’Œäººç±»iPSCsçš„RNAæµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297025">GSE297025 Tregç»†èƒå¯¹ç™½ç»†èƒä»‹ç´ -2ååº”çš„å¼‚è´¨æ€§å’ŒåŒè´¨æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287252">GSE287252 RNA-seq åˆ†æ WT å’Œ shTRIP6 RKO ç»†èƒä¹‹é—´å·®å¼‚è¡¨è¾¾åŸºå› ã€‚</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-04 21:41</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week452025/ rel=tag>Week452025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-11-04/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-04</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2025-11-06/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-06</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-18/>ç§‘ç ”æ—¥æŠ¥ 2026-01-18</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-17/>ç§‘ç ”æ—¥æŠ¥ 2026-01-17</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-16/>ç§‘ç ”æ—¥æŠ¥ 2026-01-16</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-15/>ç§‘ç ”æ—¥æŠ¥ 2026-01-15</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-01-14/>ç§‘ç ”æ—¥æŠ¥ 2026-01-14</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (81)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (81)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>